fashion -WSS

fashion

author：knowledge 2025-10-01 10:35:43 - browse：368

Adam's take main illustration — Molly Ferguson/STAT

The eye disease physician in charge of a committee that flagged a rare but severe side effect involving a newly approved drug from Apellis Pharmaceuticals has financial ties to a competing drugmaker. The conflict raises questions about his supervision of an emerging safety issue for patients and its impact on the financial health of Apellis.

Peter Kaiser, a retinal disease expert who runs the Cole Eye Institute at the Cleveland Clinic, failed to report consulting fees and stock ownership in Iveric Bio on a financial disclosure form maintained by the American Society of Retina Specialists, or ASRS. Iveric Bio is developing a treatment for geographic atrophy, a common, age-related cause of vision loss and the same indication for which the Apellis drug was approved.

The financial conflict, which was undisclosed until after Kaiser was contacted about it by STAT, is relevant because Kaiser also chairs a committee of the ASRS responsible for monitoring the safety of retina drugs and devices. On July 15, Kaiser’s committee sent a letter to member doctors, alerting them to reports of eye inflammation in people receiving injections of Syfovre, the treatment recently approved and launched by Apellis.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Brazil's Jair Bolsonaro is barred from running for office until 2030

WSS

Guardant Health colon cancer test endorsed by FDA advisory panel

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

Achieving telehealth equity for people with hearing loss

Why some fertility treatments produce more boy babies

GOP inquiry over gain

entertainment

fashion

explore

The high cost of giving birth even with insurance

Why some fertility treatments produce more boy babies

Peter Hotez and the public health issue of online harassment

Stroke rates rising, especially in working

What does generative AI mean for health care? We asked experts

Thousands protest in Iraq for a second day over burning of Quran in Sweden

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Medical experts exlpore how to eliminate bias in clinical algorithms

At least 13 dead in Texas as scorching temps continue

Ozempic cut risk of death in diabetes patients with chronic kidney disease

explore

Louisiana bill approved classifying abortion pills as controlled substances

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

The strange history of BMI, the body mass index

Lawsuit challenges CMS nursing home minimum staffing rule

Achieving telehealth equity for people with hearing loss

Brazil's Jair Bolsonaro is barred from running for office until 2030

hotspot

focus

explore

hotspot